PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
04-Dec-2024 Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001 Thermosome
28-Nov-2024 Microwave treatment promises a revolution in corn pain Emblation
28-Nov-2024 Bioanalytical Testing Services Market Witnessing Trend of Outsourcing, Revenue To Grow at CAGR 10.7% – Acumen Research And Consulting Acumen Research And Consulting
28-Nov-2024 First patients benefit from cutting-edge UK scanner to transform drug discovery and diagnose serious illnesses earlier Medicines Discovery Catapult
27-Nov-2024 Lundbeck initiates a phase III trial with amlenetug for the treatment of Multiple System Atrophy H. Lundbeck A/S
22-Nov-2024 Vetter Strengthens Senior Management Team for Further Sustainable Growth Vetter
19-Nov-2024 Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer Nouscom
19-Nov-2024 Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001 Thermosome
18-Nov-2024 CapeStart Debuts MadeAi™, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications CapeStart, Inc.
18-Nov-2024 Iqirvo® (elafibranor) data show efficacy and tolerability for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen
18-Nov-2024 Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets Cure51
14-Nov-2024 Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer Coronado Research
13-Nov-2024 New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care Lindus Health
12-Nov-2024 Gifthealth Announces Strategic Partnership with United Digestive Gifthealth
12-Nov-2024 MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease MultiOmic Health
11-Nov-2024 STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024 STORM Therapeutics
11-Nov-2024 Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting® 2024 to Support the Ongoing Phase 1/2 Study for RTX001 in End-Stage Liver Disease Resolution Therapeutics
11-Nov-2024 Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board Ebenbuild
10-Nov-2024 New GMP Training with Certificate Pharma Lessons
07-Nov-2024 PulseSight Therapeutics Presents New Data on PST-611 Transferrin Vectorized Therapy for Geographic Atrophy at EVER Congress 2024 PulseSight Therapeutics